Fair Isaac Corp (FICO) stock dropped sharply by 26.66% to a 52-week low after the Federal Housing Finance Agency (FHFA) introduced a policy allowing lenders to use VantageScore, a cheaper credit scoring alternative, in the U.S. mortgage market. This change ends FICO's pricing advantage, as VantageScore costs about $0.99 compared to FICO's $10. The policy affects government-backed mortgage giants Fannie Mae and Freddie Mac, increasing competition for FICO. Despite the drop, RBC Capital maintained an "Outperform" rating on FICO, signaling confidence in its longer-term prospects.
FICO stock's recent plunge provides context for readers interested in financial markets. For readers following the financial sector, here is Pluang's market snapshot as of Sep 30, 2026 03:22 WIB: Among 85 priced Financials-sector US stocks, 29 rose and 56 fell. Notable movers include KKR at USD 93.25 with a -3.54% change and 100% buy order activity, Prudential Financial Inc at USD 116.40 down 2.55%, and BlackRock TCP Capital Corp at USD 4.08 up 2.39%.
GameStop's CEO Ryan Cohen and other executives have made significant insider purchases of millions of shares, showing strong confidence in the company's future despite recent stock price volatility. These buys were active decisions, not pre-scheduled...
Concentrix Corporation reported mixed Q3 2026 results with earnings per share of $2.92, beating analyst expectations of $2.71. However, its revenue of $2.45 billion slightly missed the forecast of $2.48 billion. The company achieved a record free cas...
Accenture is set to report Q3 2026 earnings on October 1, with analysts forecasting $18.03 billion in revenue, a 5.6% increase year-over-year, and earnings per share around $3.18. The growth is fueled by strong demand for AI services, with 100 new ad...
Iovance Biotherapeutics shares jumped 31.48% after raising its 2026 revenue forecast, driven by strong demand for its cancer immunotherapy Amtagvi. SoundThinking's stock rose 50.09% following an acquisition agreement with Transom Capital Group, offer...
Shares of uniQure dropped 37.33% following mixed clinical data for its Huntington's disease gene therapy. Fair Isaac fell 26.52% after U.S. regulators expanded the use of competitor VantageScore in mortgage credit scoring, threatening its market posi...
